Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Clopidogrel outshines aspirin for secondary prevention in high-risk PCI patients

11 Apr 2025 bởi

In the long-term maintenance period after percutaneous coronary intervention (PCI), monotherapy with clopidogrel appears to work better than aspirin at preventing major adverse cardiac and cerebrovascular events in Asian patients at high risk of recurrent ischaemic events, as shown in the open-label SMART-CHOICE 3 trial conducted in South Korea.

Clopidogrel outshines aspirin for secondary prevention in high-risk PCI patients

11 Apr 2025

Dapagliflozin after TAVI improves outcomes in elderly patients with aortic stenosis

10 Apr 2025 bởi

Elderly patients with aortic stenosis who received dapagliflozin after transcatheter aortic-valve implantation (TAVI) had better outcomes than those who did not receive the drug, according to the DapaTAVI* trial presented at ACC.25.

Dapagliflozin after TAVI improves outcomes in elderly patients with aortic stenosis

10 Apr 2025

Original New Drug Application Approvals by US FDA (16-31 March 2025)

10 Apr 2025

New drug applications approved by US FDA as of 16-31 March 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 March 2025)

10 Apr 2025

Women more likely than men to receive high-intensity statins for secondary prevention post-CABG

09 Apr 2025

Women are more likely than men to fill prescriptions for statin, particularly high-intensity dosages, after undergoing coronary artery bypass surgery (CABG), with statin therapy equally effective at reducing mortality for both sexes, according to a study.

Women more likely than men to receive high-intensity statins for secondary prevention post-CABG

09 Apr 2025

Heart failure precedes rapid, sustained cognitive decline

08 Apr 2025 bởi

A rapid and persistent deterioration in cognitive function appears to occur following the onset of heart failure (HF), as reported in a study.

Heart failure precedes rapid, sustained cognitive decline

08 Apr 2025

What’s new in the 2025 ACS Guidelines?

08 Apr 2025 bởi

The American College of Cardiology and the American Heart Association (ACC/AHA) have issued new guidelines for managing acute coronary syndromes (ACS), outlining strategies for lipid management, minimizing bleeding risk, and considerations related to procedural care.

What’s new in the 2025 ACS Guidelines?

08 Apr 2025

Over-the-counter magnesium supplements help lower cardiovascular risk in diabetes

05 Apr 2025

Long-term use of over-the-counter magnesium supplements appears to have cardioprotective benefits in patients with diabetes, having been shown to reduce the risk of heart failure (HF) and major adverse cardiac events, according to a study.

Over-the-counter magnesium supplements help lower cardiovascular risk in diabetes

05 Apr 2025

Original New Drug Application Approvals by US FDA (1-15 March 2025)

04 Apr 2025

New drug applications approved by US FDA as of 1-15 March 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 March 2025)

04 Apr 2025

Fluoxetine boosts good cholesterol, lowers triglycerides in people with obesity

31 Mar 2025

The selective serotonin reuptake inhibitor fluoxetine appears to modify lipid profile in individuals with overweight or obesity, with triglyceride levels reduced and high-density lipoprotein cholesterol (HDL-C) levels increased, according to a systematic review and meta-analysis.

Fluoxetine boosts good cholesterol, lowers triglycerides in people with obesity

31 Mar 2025

OSA, anaemia show synergistic effect on hypertension

28 Mar 2025

Anaemia and obstructive sleep apnoea (OSA) appear to have a combined impact on the incidence of hypertension, suggests a study.

OSA, anaemia show synergistic effect on hypertension

28 Mar 2025

Tin tức & Cập nhật

Xem bài viết Tim mạch

Xem

Chuyên ngành:

Clopidogrel outshines aspirin for secondary prevention in high-risk PCI patients

Clopidogrel outshines aspirin for secondary prevention in high-risk PCI patients

Dapagliflozin after TAVI improves outcomes in elderly patients with aortic stenosis

Dapagliflozin after TAVI improves outcomes in elderly patients with aortic stenosis

Original New Drug Application Approvals by US FDA (16-31 March 2025)

Original New Drug Application Approvals by US FDA (16-31 March 2025)

Women more likely than men to receive high-intensity statins for secondary prevention post-CABG

Women more likely than men to receive high-intensity statins for secondary prevention post-CABG

Heart failure precedes rapid, sustained cognitive decline

Heart failure precedes rapid, sustained cognitive decline

What’s new in the 2025 ACS Guidelines?

What’s new in the 2025 ACS Guidelines?

Over-the-counter magnesium supplements help lower cardiovascular risk in diabetes

Over-the-counter magnesium supplements help lower cardiovascular risk in diabetes

Original New Drug Application Approvals by US FDA (1-15 March 2025)

Original New Drug Application Approvals by US FDA (1-15 March 2025)

Fluoxetine boosts good cholesterol, lowers triglycerides in people with obesity

Fluoxetine boosts good cholesterol, lowers triglycerides in people with obesity

OSA, anaemia show synergistic effect on hypertension

OSA, anaemia show synergistic effect on hypertension